Phase II study of deoxydoxorubicin in patients with advanced liver cancer.
D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D003953:Diagnosis-Related Groups; D004317:Doxorubicin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin; C030851:esorubicin